|
U.S. FDA authorizes Moderna's COVID-19 vaccine for emergency use |
mike kraft |
Group Post |
12/18/20 |
|
U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old |
mike kraft |
Group Post |
12/08/22 |
|
U.S. FDA authorizes Novavax's COVID vaccine as booster for adults |
mike kraft |
Group Post |
10/19/22 |
|
U.S. FDA authorizes Pfizer/BioNTech booster for 16- and 17-year-olds |
mike kraft |
Group Post |
12/09/21 |
|
U.S. FDA authorizes spring covid booster shots for older adults and the immunocompromised |
mike kraft |
Group Post |
04/18/23 |
|
U.S. FDA authorizes use of AstraZeneca COVID-19 antibody cocktail |
mike kraft |
Group Post |
12/08/21 |
|
U.S. FDA clears updated COVID boosters for kids as young as 5 |
mike kraft |
Group Post |
10/12/22 |
|
U.S. FDA cuts gap for Moderna COVID-19 booster dose to 5 months |
mike kraft |
Group Post |
01/07/22 |
|
U.S. FDA gearing up for rapid review of potential COVID-19 booster shots |
mike kraft |
Group Post |
02/05/21 |
|
U.S. FDA grants full approval to Pfizer COVID vaccine for ages 12-15 |
mike kraft |
Group Post |
07/08/22 |
|
U.S. FDA has not seen possible side-effects of COVID shots being studied in EU |
mike kraft |
Group Post |
08/12/21 |
|
U.S. FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, increased cases |
mike kraft |
Group Post |
06/17/24 |
|
U.S. FDA OKs another Pfizer, Moderna COVID booster for 50 and up |
mike kraft |
Group Post |
03/29/22 |
|
U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill |
mike kraft |
Group Post |
11/30/21 |
|
U.S. FDA panel narrowly backs Pfizer RSV vaccine for older adults |
mike kraft |
Group Post |
03/01/23 |
|
U.S. FDA panel recomends retiring original Covid vaccine and using newer versions |
mike kraft |
Group Post |
01/27/23 |
|
U.S. FDA panel recommends booster shots for Johnson & Johnson vaccine |
mike kraft |
Group Post |
10/15/21 |
|
U.S. FDA panel to advise on whether — and how — Covid vaccines should be updated |
mike kraft |
Group Post |
06/27/22 |
|
U.S. FDA panel unanimously votes in favor of RSV antibody treatment for infants |
mike kraft |
Group Post |
06/08/23 |
|
U.S. FDA proposes major shift to annual COVID vaccine strategy--one shot annually |
mike kraft |
Group Post |
01/23/23 |
|
U.S. FDA recalls supplement claiming COVID-related health benefits |
mike kraft |
Group Post |
03/10/23 |
|
U.S. FDA removes COVID test requirements before prescribing Pfizer, Merck treatment pills |
mike kraft |
Group Post |
02/01/23 |
|
U.S. FDA reportedly wil allow mixing and matching of COVID-19 boosters |
mike kraft |
Group Post |
10/18/21 |
|
U.S. FDA says robust safety data needed before COVID-19 vaccine approval for kids |
mike kraft |
Group Post |
09/10/21 |
|
U.S. FDA settles lawsuit over its criticisms of using ivermectin to counter COVID |
mike kraft |
Group Post |
03/29/24 |
|
U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boosters |
mike kraft |
Group Post |
10/12/21 |
|
U.S. FDA vaccine advisers reported upset that early data about new Moderna Covid-19 booster shot wasn’t presented for review last year |
mike kraft |
Group Post |
01/11/23 |
|
U.S. FDA vaccine advisers vote against COVID-19 booster shot approval for most Americans, but may vote later on shots for older persons |
mike kraft |
Group Post |
09/17/21 |
|
U.S. FDA warns about using over-the-counter COVID-19 tests from Cue Health |
mike kraft |
Group Post |
05/14/24 |
|
U.S. federal advisory on Long COVID link to mental health conditions |
mike kraft |
Group Post |
06/23/23 |
|
U.S. federal judge Judge throws out Missouri COVID-19 suit against China |
mike kraft |
Group Post |
07/11/22 |
|
U.S. FEMA official concerned about China and Russia spreading disinformation after disasters. |
mike kraft |
Group Post |
12/12/23 |
|
U.S. fights COVID-19 surge amid record new cases |
mike kraft |
Group Post |
11/04/20 |
|
U.S. Flu and COVID rising infections could get worse over the holidays -- CDC |
mike kraft |
Group Post |
12/22/23 |
|
U.S. Flu continues to spread across the country, infecting millions, CDC reports |
mike kraft |
Group Post |
11/29/22 |
|
U.S. Food and Drug Administration has decided not to authorize the antidepressant fluvoxamine to treat COVID-19 |
mike kraft |
Group Post |
05/17/22 |
|
U.S. GAO releases recommendations aimed at future pandemics |
mike kraft |
Group Post |
07/12/23 |
|
U.S. goal to squeeze more COVID shots from Pfizer vials hampered by syringe production |
mike kraft |
Group Post |
01/25/21 |
|
U.S. Goverment awards $1.4 billion to develop new Covid-19 vaccines and therapies |
mike kraft |
Group Post |
08/23/23 |
|
U.S. government buys another 100 million doses of Moderna vaccine |
mike kraft |
Group Post |
12/12/20 |
|
U.S. government COVID vaccine campaign saved $732 billion in averted infections, costs --study |
mike kraft |
Group Post |
05/08/24 |
|
U.S. government develops plan to produce 4.8 million H5N1 bird flu vaccine doses |
mike kraft |
Group Post |
05/23/24 |
|
U.S. Government expected to approve COVID booster shots soon |
mike kraft |
Group Post |
08/17/21 |
|
U.S. government funding for Covid vaccines ends in August for persons with little or no health insurance |
mike kraft |
Group Post |
05/23/24 |
|
U.S. Government program to develop the next generation of Covid vaccines makes $433 million research grant |
mike kraft |
Group Post |
09/27/23 |
|
U.S. government spent more on health care in 2022 than six countries with universal health care combined |
mike kraft |
Group Post |
12/20/23 |
|
U.S. has stockpiled millions of doses of two smallpox vaccines, also effective against monkeypox. But the outbreaks so far are clustered in other countries. |
mike kraft |
Group Post |
05/24/22 |
|
U.S. Health and Human Services (HHS) withdraws Trump administration policy that limited FDA review of certain Covid-19 tests |
mike kraft |
Group Post |
11/16/21 |
|
U.S. health officials and an oversight board accused AstraZeneca of presenting potentially misleading information |
mike kraft |
Group Post |
03/23/21 |
|
U.S. health officials make new push for inoculations in face of declining vaccination rates |
mike kraft |
Group Post |
09/28/23 |
Recent Comments